DE60334924D1 - Anoteilchengrösse - Google Patents
AnoteilchengrösseInfo
- Publication number
- DE60334924D1 DE60334924D1 DE60334924T DE60334924T DE60334924D1 DE 60334924 D1 DE60334924 D1 DE 60334924D1 DE 60334924 T DE60334924 T DE 60334924T DE 60334924 T DE60334924 T DE 60334924T DE 60334924 D1 DE60334924 D1 DE 60334924D1
- Authority
- DE
- Germany
- Prior art keywords
- active agent
- solid
- dosage form
- semi
- gelatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40958702P | 2002-09-11 | 2002-09-11 | |
| PCT/US2003/028380 WO2005000265A2 (en) | 2002-09-11 | 2003-09-11 | Gel-stabilized nanoparticulate active agent compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60334924D1 true DE60334924D1 (de) | 2010-12-23 |
Family
ID=33551184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60334924T Expired - Lifetime DE60334924D1 (de) | 2002-09-11 | 2003-09-11 | Anoteilchengrösse |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7713551B2 (de) |
| EP (1) | EP1553927B9 (de) |
| JP (1) | JP4878839B2 (de) |
| AT (1) | ATE487470T1 (de) |
| AU (1) | AU2003304237A1 (de) |
| CA (1) | CA2498207C (de) |
| CY (1) | CY1110949T1 (de) |
| DE (1) | DE60334924D1 (de) |
| DK (1) | DK1553927T3 (de) |
| ES (1) | ES2355723T3 (de) |
| PT (1) | PT1553927E (de) |
| SI (1) | SI1553927T1 (de) |
| WO (1) | WO2005000265A2 (de) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080102121A1 (en) * | 1998-11-02 | 2008-05-01 | Elan Pharma International Limited | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| US20080113025A1 (en) * | 1998-11-02 | 2008-05-15 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| WO2000025752A1 (en) * | 1998-11-02 | 2000-05-11 | Church, Marla, J. | Multiparticulate modified release composition |
| CA2359945C (en) * | 1999-11-12 | 2011-04-26 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| US20030206958A1 (en) * | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
| US7758890B2 (en) * | 2001-06-23 | 2010-07-20 | Lyotropic Therapeutics, Inc. | Treatment using dantrolene |
| US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| PT1471887E (pt) * | 2002-02-04 | 2010-07-16 | Elan Pharma Int Ltd | Composiães de nanopartculas com lisozima como um estabilizador superficial |
| CA2502825A1 (en) * | 2002-10-22 | 2004-05-06 | Dainippon Pharmaceutical Co., Ltd. | Stabilized composition |
| PL377477A1 (pl) * | 2002-12-11 | 2006-02-06 | Ferrosan A/S | Materiały na bazie żelatyny jako waciki |
| CA2522708C (en) | 2003-04-29 | 2013-05-28 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss |
| US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US7923031B2 (en) * | 2004-01-30 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic sprays and compositions |
| EP1742612A2 (de) * | 2004-05-06 | 2007-01-17 | Ivrea Pharmaceuticals, Inc. | Partikel zur wirkstofffreisetzung |
| CN101001649B (zh) * | 2004-07-09 | 2011-08-31 | 弗罗桑医疗设备公司 | 包括透明质酸的止血组合物及其制备方法 |
| DE102004041340A1 (de) * | 2004-08-20 | 2006-02-23 | Deutsche Gelatine-Fabriken Stoess Ag | Nanopartikel und Verfahren zu deren Herstellung |
| UA89513C2 (uk) * | 2004-12-03 | 2010-02-10 | Элан Фарма Интернешнл Лтд. | Стабільна композиція з наночастинок ралоксифену гідрохлориду |
| WO2006088894A2 (en) * | 2005-02-15 | 2006-08-24 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| EP1855651A4 (de) * | 2005-03-03 | 2011-06-15 | Elan Pharma Int Ltd | Nanopartikelzusammensetzungen heterocyclischer amidderivate |
| US20110064803A1 (en) * | 2005-05-10 | 2011-03-17 | Elan Pharma International Limited. | Nanoparticulate and controlled release compositions comprising vitamin k2 |
| EA200702444A1 (ru) * | 2005-05-10 | 2008-04-28 | Элан Фарма Интернэшнл Лимитед | Композиции с наночастицами клопидогреля |
| US20100028439A1 (en) * | 2005-05-23 | 2010-02-04 | Elan Pharma International Limited | Nanoparticulate stabilized anti-hypertensive compositions |
| US20070042049A1 (en) * | 2005-06-03 | 2007-02-22 | Elan Pharma International, Limited | Nanoparticulate benidipine compositions |
| AU2006255177A1 (en) * | 2005-06-03 | 2006-12-14 | Elan Pharma International, Limited | Nanoparticulate imatinib mesylate formulations |
| US20060292214A1 (en) * | 2005-06-03 | 2006-12-28 | Elan Pharma International Limited | Nanoparticulate acetaminophen formulations |
| EP1954253A4 (de) | 2005-06-08 | 2011-07-27 | Elan Pharma Int Ltd | Nanoteilchenförmige und kontrolliert freigesetzte zusammensetzungen mit cefditoren |
| WO2007037790A2 (en) * | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Modified release famciclovir compositions |
| EP1898882B1 (de) * | 2005-06-09 | 2009-10-28 | Elan Pharma International Limited | Nanopartikuläre ebastinformulierungen |
| AU2006259606A1 (en) * | 2005-06-13 | 2006-12-28 | Elan Pharma International, Limited | Nanoparticulate clopidogrel and aspirin combination formulations |
| EP1931340A2 (de) * | 2005-06-15 | 2008-06-18 | Elan Pharma International Limited | Nanopartikuläre azelnidipin-formulierungen |
| US9119899B2 (en) * | 2006-01-18 | 2015-09-01 | Cormatrix Cardiovascular, Inc. | Method and system for treatment of cardiovascular disorders |
| CA2622200A1 (en) * | 2005-09-13 | 2007-03-22 | Elan Pharma International, Limited | Nanoparticulate tadalafil formulations |
| JP2009508859A (ja) * | 2005-09-15 | 2009-03-05 | エラン ファーマ インターナショナル リミテッド | ナノ粒子アリピプラゾール製剤 |
| ES2761812T3 (es) * | 2005-11-22 | 2020-05-21 | Nalpropion Pharmaceuticals Inc | Composición y métodos de aumento de la sensibilidad a la insulina |
| CN106667918A (zh) * | 2005-11-28 | 2017-05-17 | 马里纳斯医药公司 | 加奈索酮组合物及其制备和使用方法 |
| WO2007062228A1 (en) * | 2005-11-28 | 2007-05-31 | Orexigen Therapeutics, Inc. | Sustained-release formulation of zonisamide |
| WO2007066147A1 (en) * | 2005-12-07 | 2007-06-14 | Pharmakodex Ltd | Topical compositions for paediatric use |
| CN103265495B (zh) | 2005-12-29 | 2016-11-16 | 莱西肯医药有限公司 | 多环氨基酸衍生物及其使用方法 |
| US7649098B2 (en) | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| US8187659B2 (en) | 2006-05-02 | 2012-05-29 | Jerry Robertson Real Estate Llc | Solid medicament dosage form consumption aid |
| WO2007139367A1 (es) * | 2006-05-26 | 2007-12-06 | Cruz Serrano Jose Antonio | Alimento gelatinoso proteico y su proceso de elaboración |
| SG170047A1 (en) | 2006-05-30 | 2011-04-29 | Elan Pharma Int Ltd | Nanoparticulate posaconazole formulations |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| WO2007150074A2 (en) * | 2006-06-23 | 2007-12-27 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| EP2049084A2 (de) * | 2006-07-10 | 2009-04-22 | Elan Pharma International Limited | Nanoteilchenförmige sorafenib-formulierungen |
| KR100809903B1 (ko) | 2006-09-05 | 2008-03-06 | 주식회사유한양행 | 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물 |
| KR101971218B1 (ko) | 2006-11-09 | 2019-08-27 | 오렉시젠 세러퓨틱스 인크. | 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형 |
| AU2007319472B2 (en) | 2006-11-09 | 2013-01-17 | Nalpropion Pharmaceuticals Llc | Methods Of Administering Weight Loss Medications |
| AU2007325628A1 (en) * | 2006-11-28 | 2008-06-05 | Marinus Pharmaceuticals | Nanoparticulate formulations and methods for the making and use thereof |
| UA99270C2 (en) | 2006-12-12 | 2012-08-10 | Лексикон Фармасьютикалз, Инк. | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| CA2684985A1 (en) * | 2007-03-16 | 2008-09-25 | Elan Pharma International Limited | Combination of a narcotic and a non-narcotic analgesic |
| KR100761040B1 (ko) | 2007-03-22 | 2007-10-04 | 현대약품 주식회사 | 산 불안정성 벤즈이미다졸계 화합물을 포함하는 약학조성물 |
| KR100761041B1 (ko) | 2007-03-22 | 2007-10-04 | 현대약품 주식회사 | 산 불안정성 벤즈이미다졸계 화합물을 포함하는 약학조성물 |
| US8119600B2 (en) * | 2007-04-10 | 2012-02-21 | Stefano Ferrari | Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology |
| JP4941977B2 (ja) * | 2007-04-11 | 2012-05-30 | 大蔵製薬株式会社 | ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物 |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| PT103765A (pt) * | 2007-06-20 | 2008-12-22 | Inst Superior Tecnico | Síntese e aplicação de uma família de novos materiais resultantes do cruzamento entre gelatina e sais orgânicos |
| WO2009073205A1 (en) * | 2007-12-07 | 2009-06-11 | Biocure, Inc. | Bone substitute |
| US20090155363A1 (en) * | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
| WO2009109194A2 (en) * | 2008-02-29 | 2009-09-11 | Ferrosan A/S | Device for promotion of hemostasis and/or wound healing |
| US8389012B2 (en) * | 2008-03-07 | 2013-03-05 | The Corporation Of Mercer University | Gellan-gum nanoparticles and methods of making and using the same |
| KR20110007095A (ko) * | 2008-03-21 | 2011-01-21 | 엘란 파마 인터내셔널 리미티드 | 이마티니브의 부위-특이적 전달을 위한 조성물 및 사용방법 |
| WO2009158114A1 (en) * | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| US9498440B2 (en) | 2009-05-22 | 2016-11-22 | Inventia Healthcare Private Limited | Extended release pharmaceutical compositions |
| EP3167875A1 (de) | 2009-05-27 | 2017-05-17 | Alkermes Pharma Ireland Limited | Reduktion von flockenartiger aggregation in nanoteilchenförmigen meloxicamzusammensetzungen |
| AU2010261510A1 (en) * | 2009-06-19 | 2012-02-09 | Nanoform Hungary Ltd. | Nanostructured Sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| US9775819B2 (en) * | 2009-09-16 | 2017-10-03 | R.P. Scherer Technologies, Llc | Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin |
| WO2011056916A1 (en) | 2009-11-05 | 2011-05-12 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of cancer |
| EP2523557B1 (de) | 2010-01-11 | 2019-09-25 | Nalpropion Pharmaceuticals, Inc. | Verfahren zur bereitstellung einer gewichtsverlusttherapie für patienten mit schweren depressionen |
| CA2789229A1 (en) | 2010-02-10 | 2011-08-18 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
| GB201006218D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| US9012511B2 (en) | 2010-05-19 | 2015-04-21 | Alkermes Pharma Ireland Limited | Nanoparticulate cinacalcet compositions |
| US9018193B2 (en) | 2010-09-13 | 2015-04-28 | Bev-Rx, Inc. | Aqueous drug delivery system |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| EP2672983B1 (de) * | 2011-02-11 | 2017-04-19 | Edge Therapeutics, Inc. | Zusammensetzungen und verfahren zur verbesserung der prognose für einen patienten mit subarachnoider blutung |
| CA2832501A1 (en) | 2011-04-05 | 2012-10-11 | R. Loch Macdonald | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
| EP3178470A1 (de) * | 2011-04-11 | 2017-06-14 | Vitux Group AS | Orale pharmazeutische dispersionszusammensetzungen |
| EP2540287A1 (de) | 2011-07-01 | 2013-01-02 | FutureChemistry | Fließfertigung von Gelatine-Nanoteilchen |
| WO2013035423A1 (ja) * | 2011-09-09 | 2013-03-14 | 東洋カプセル株式会社 | カンデサルタンシレキセチル含有医薬組成物 |
| CN104159527B (zh) | 2012-03-06 | 2017-04-12 | 弗罗桑医疗设备公司 | 包含止血糊剂的压力容器 |
| US9452135B2 (en) | 2012-03-20 | 2016-09-27 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
| US20130303763A1 (en) | 2012-03-30 | 2013-11-14 | Michael D. Gershon | Methods and compositions for the treatment of necrotizing enterocolitis |
| PT2858640T (pt) | 2012-06-06 | 2020-06-30 | Nalpropion Pharmaceuticals Llc | Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular |
| BR112014030962A2 (pt) | 2012-06-12 | 2017-06-27 | Ferrosan Medical Devices As | métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático |
| FR2999086B1 (fr) * | 2012-12-10 | 2015-04-10 | Ethypharm Sa | Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation |
| WO2014202760A2 (en) | 2013-06-21 | 2014-12-24 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| EP3082428A4 (de) | 2013-12-09 | 2017-08-02 | Respira Therapeutics, Inc. | Pde5-inhibitorpulverformulierungen und zugehörige verfahren |
| BR112016013322B1 (pt) | 2013-12-11 | 2020-07-21 | Ferrosan Medical Devices A/S | métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit |
| BR112017007466B1 (pt) | 2014-10-13 | 2021-03-02 | Ferrosan Medical Devices A/S | método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca |
| EP3237041B1 (de) | 2014-12-24 | 2020-01-29 | Ferrosan Medical Devices A/S | Spritze für die enthaltung und die mischung erster und zweiter substanzen |
| KR20160081646A (ko) * | 2014-12-31 | 2016-07-08 | 건일제약 주식회사 | 멜라토닌 및 설트랄린을 포함하는 경구용 복합정제 |
| CN105981748B (zh) * | 2015-05-07 | 2018-12-04 | 博约生物科技(苏州)有限公司 | 一种提取天然抑菌剂有效成分的方法 |
| WO2017005590A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| MX2018004376A (es) | 2015-10-16 | 2018-08-01 | Marinus Pharmaceuticals Inc | Formulaciones inyectables de neuroesteroides que contienen nanoparticulas. |
| WO2018031748A1 (en) | 2016-08-11 | 2018-02-15 | Ovid Therapeutics Inc. | Methods and compositions for treatment of epileptic disorders |
| US10391105B2 (en) | 2016-09-09 | 2019-08-27 | Marinus Pharmaceuticals Inc. | Methods of treating certain depressive disorders and delirium tremens |
| WO2019072877A1 (en) | 2017-10-10 | 2019-04-18 | Capsugel Belgium Nv | GETTING MULTIPARTICULAR COMPOSITIONS |
| AU2019266529B2 (en) | 2018-05-09 | 2024-05-23 | Ethicon Inc. | Method for preparing a haemostatic composition |
| US11266662B2 (en) | 2018-12-07 | 2022-03-08 | Marinus Pharmaceuticals, Inc. | Ganaxolone for use in prophylaxis and treatment of postpartum depression |
| EP4009982A4 (de) | 2019-08-05 | 2023-08-09 | Marinus Pharmaceuticals, Inc. | Ganaxolon zur verwendung bei der behandlung von status epilepticus |
| KR20220134529A (ko) | 2019-12-06 | 2022-10-05 | 마리누스 파마슈티컬스 인코포레이티드 | 복합 결절성 경화증의 치료에 사용하기 위한 가낙솔론 |
| US11071739B1 (en) | 2020-09-29 | 2021-07-27 | Genus Lifesciences Inc. | Oral liquid compositions including chlorpromazine |
| EP4122453A1 (de) * | 2021-07-22 | 2023-01-25 | Universität Heidelberg | Thermoreversible gelatinematrix zur stabilitätsverbesserung und gebrauchsfertige flüssige anwendung von nanopartikeln und kolloidalen arzneimitteln |
| JP2025507801A (ja) | 2022-03-02 | 2025-03-21 | ホライゾン セラピューティクス アイルランド デジグネイテッド アクティビティ カンパニー | 結晶性ｅｄｇ－２受容体拮抗薬を作製する方法 |
| CN117186267B (zh) * | 2022-05-31 | 2025-01-28 | 杭州协合医疗用品有限公司 | 一种羟丁基甲壳素、羟丁基甲壳素水凝胶及制备方法 |
| KR20250149910A (ko) * | 2024-04-10 | 2025-10-17 | 주식회사 인벤테라 | 림프관으로 배출 가능하고 면역원성이 감소된 다당류 가교 콜로이드 입자 기반 기능성 약물 |
Family Cites Families (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4003999A (en) * | 1972-10-25 | 1977-01-18 | A. H. Robins Company, Incorporated | Aspirin-tea coprecipitates for treating inflammation |
| US4486412A (en) * | 1983-03-15 | 1984-12-04 | Pharmacaps, Inc. | Encapsulated antacid dispersions |
| US4826689A (en) | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| US4783484A (en) | 1984-10-05 | 1988-11-08 | University Of Rochester | Particulate composition and use thereof as antimicrobial agent |
| US4882157A (en) * | 1985-12-20 | 1989-11-21 | Yang Robert K | Confectionery delivery system for anti-cholesterolemics |
| US4778676A (en) * | 1985-12-20 | 1988-10-18 | Warner-Lambert Company | Confectionery delivery system for actives |
| US4795642A (en) * | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US4837255A (en) * | 1987-03-10 | 1989-06-06 | Ciba-Geigy Corporation | Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
| US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
| US6482516B1 (en) * | 1993-07-20 | 2002-11-19 | Banner Pharmacaps, Inc. | Enrobed tablet |
| US5146730A (en) * | 1989-09-20 | 1992-09-15 | Banner Gelatin Products Corp. | Film-enrobed unitary-core medicament and the like |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5552160A (en) * | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
| AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| JPH06511481A (ja) | 1991-07-05 | 1994-12-22 | ユニバーシティ オブ ロチェスター | 気泡を取り込む超微小非凝集多孔質粒子 |
| US5200191A (en) * | 1991-09-11 | 1993-04-06 | Banner Gelatin Products Corp. | Softgel manufacturing process |
| DE4140179C2 (de) | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Ibuprofen enthaltendes Arzneimittel |
| ES2087565T3 (es) * | 1991-12-05 | 1996-07-16 | Alfatec Pharma Gmbh | Nanosol aplicable farmaceuticamente y procedimiento para su preparacion. |
| NZ248813A (en) * | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
| US5349957A (en) * | 1992-12-02 | 1994-09-27 | Sterling Winthrop Inc. | Preparation and magnetic properties of very small magnetite-dextran particles |
| US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| US5298262A (en) | 1992-12-04 | 1994-03-29 | Sterling Winthrop Inc. | Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| US5302401A (en) | 1992-12-09 | 1994-04-12 | Sterling Winthrop Inc. | Method to reduce particle size growth during lyophilization |
| US5340564A (en) * | 1992-12-10 | 1994-08-23 | Sterling Winthrop Inc. | Formulations comprising olin 10-G to prevent particle aggregation and increase stability |
| US5336507A (en) * | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
| US5429824A (en) * | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
| US5352459A (en) * | 1992-12-16 | 1994-10-04 | Sterling Winthrop Inc. | Use of purified surface modifiers to prevent particle aggregation during sterilization |
| US5401492A (en) * | 1992-12-17 | 1995-03-28 | Sterling Winthrop, Inc. | Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents |
| US5326552A (en) * | 1992-12-17 | 1994-07-05 | Sterling Winthrop Inc. | Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants |
| US5264610A (en) * | 1993-03-29 | 1993-11-23 | Sterling Winthrop Inc. | Iodinated aromatic propanedioates |
| US5718388A (en) * | 1994-05-25 | 1998-02-17 | Eastman Kodak | Continuous method of grinding pharmaceutical substances |
| TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
| US5525328A (en) * | 1994-06-24 | 1996-06-11 | Nanosystems L.L.C. | Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging |
| US5587143A (en) * | 1994-06-28 | 1996-12-24 | Nanosystems L.L.C. | Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
| NZ280610A (en) * | 1994-12-29 | 1997-08-22 | Mcneil Ppc Inc | Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent |
| US5628981A (en) * | 1994-12-30 | 1997-05-13 | Nano Systems L.L.C. | Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents |
| US5466440A (en) * | 1994-12-30 | 1995-11-14 | Eastman Kodak Company | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays |
| US5585108A (en) * | 1994-12-30 | 1996-12-17 | Nanosystems L.L.C. | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| US5569448A (en) * | 1995-01-24 | 1996-10-29 | Nano Systems L.L.C. | Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
| US5560931A (en) * | 1995-02-14 | 1996-10-01 | Nawosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US5571536A (en) * | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US5593657A (en) * | 1995-02-09 | 1997-01-14 | Nanosystems L.L.C. | Barium salt formulations stabilized by non-ionic and anionic stabilizers |
| US5622938A (en) * | 1995-02-09 | 1997-04-22 | Nano Systems L.L.C. | Sugar base surfactant for nanocrystals |
| US5534270A (en) * | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
| US5518738A (en) * | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
| US5500204A (en) * | 1995-02-10 | 1996-03-19 | Eastman Kodak Company | Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging |
| US5591456A (en) * | 1995-02-10 | 1997-01-07 | Nanosystems L.L.C. | Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer |
| US5573783A (en) * | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
| US5543133A (en) * | 1995-02-14 | 1996-08-06 | Nanosystems L.L.C. | Process of preparing x-ray contrast compositions containing nanoparticles |
| US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
| US5580579A (en) * | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
| US5718919A (en) * | 1995-02-24 | 1998-02-17 | Nanosystems L.L.C. | Nanoparticles containing the R(-)enantiomer of ibuprofen |
| JP4484247B2 (ja) * | 1995-02-24 | 2010-06-16 | エラン ファーマ インターナショナル，リミティド | ナノ粒子分散体を含有するエアロゾル |
| US5565188A (en) * | 1995-02-24 | 1996-10-15 | Nanosystems L.L.C. | Polyalkylene block copolymers as surface modifiers for nanoparticles |
| US5643552A (en) * | 1995-03-09 | 1997-07-01 | Nanosystems L.L.C. | Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray contrast agents for blood pool and lymphatic system imaging |
| US5472683A (en) * | 1995-03-09 | 1995-12-05 | Eastman Kodak Company | Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging |
| US5573749A (en) * | 1995-03-09 | 1996-11-12 | Nano Systems L.L.C. | Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging |
| US5521218A (en) * | 1995-05-15 | 1996-05-28 | Nanosystems L.L.C. | Nanoparticulate iodipamide derivatives for use as x-ray contrast agents |
| US5573750A (en) * | 1995-05-22 | 1996-11-12 | Nanosystems L.L.C. | Diagnostic imaging x-ray contrast agents |
| ES2168481T3 (es) | 1995-06-09 | 2002-06-16 | Scherer Technologies Inc R P | Capsulas de gelatina blanda conteniendo un material en particulas. |
| CA2231870C (en) * | 1995-09-19 | 2005-02-22 | Alcan International Limited | Precipitation-hardened aluminum alloys for automotive structural applications |
| US5834025A (en) * | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| WO1998035666A1 (en) * | 1997-02-13 | 1998-08-20 | Nanosystems Llc | Formulations of nanoparticle naproxen tablets |
| US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| US6197787B1 (en) * | 1997-03-03 | 2001-03-06 | Sanofi-Synthelabo | Pharmaceutical formulations containing poorly soluble drug substances |
| NL1009107C2 (nl) * | 1997-11-12 | 1999-06-15 | Banner Pharmacaps Inc | Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel. |
| US6432442B1 (en) | 1998-02-23 | 2002-08-13 | Mcneil-Ppc, Inc. | Chewable product |
| US6153225A (en) * | 1998-08-13 | 2000-11-28 | Elan Pharma International Limited | Injectable formulations of nanoparticulate naproxen |
| US6165506A (en) * | 1998-09-04 | 2000-12-26 | Elan Pharma International Ltd. | Solid dose form of nanoparticulate naproxen |
| US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| JP2002525311A (ja) * | 1998-10-01 | 2002-08-13 | エラン ファーマ インターナショナル，リミティド | 徐放性ナノ粒子組成物 |
| US6375986B1 (en) * | 2000-09-21 | 2002-04-23 | Elan Pharma International Ltd. | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
| US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| US6270806B1 (en) * | 1999-03-03 | 2001-08-07 | Elan Pharma International Limited | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| US6258380B1 (en) * | 1999-03-05 | 2001-07-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
| US6267989B1 (en) | 1999-03-08 | 2001-07-31 | Klan Pharma International Ltd. | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
| US6431478B1 (en) * | 1999-06-01 | 2002-08-13 | Elan Pharma International Limited | Small-scale mill and method thereof |
| US6251426B1 (en) * | 1999-09-02 | 2001-06-26 | Banner Pharmacaps, Inc. | Ibuprofen-containing softgels |
| EP1313564B1 (de) * | 2000-04-26 | 2009-12-30 | Elan Pharma International Limited | Vorrichtung zur sanitären nassvermahlung |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US6685961B1 (en) * | 2000-10-24 | 2004-02-03 | Banner Pharmacaps, Inc. | Colored gelatin-based formulations and method |
| AU2002312230A1 (en) | 2001-06-05 | 2002-12-16 | Elan Pharma International Limited | System and method for milling materials |
| US6949256B2 (en) * | 2002-01-18 | 2005-09-27 | Banner Pharmacaps, Inc. | Non-gelatin capsule shell formulation |
| DE10244504A1 (de) * | 2002-09-25 | 2004-04-08 | Capsulution Nanoscience Ag | Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff |
| US20060088590A1 (en) * | 2004-10-22 | 2006-04-27 | Banner Pharmacaps, Inc. | Non-blooming gelatin and non-gelatin formulations |
| WO2007050975A2 (en) * | 2005-10-26 | 2007-05-03 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system as capsule fill |
| US20070148248A1 (en) * | 2005-12-22 | 2007-06-28 | Banner Pharmacaps, Inc. | Gastric reflux resistant dosage forms |
-
2003
- 2003-09-11 JP JP2005503259A patent/JP4878839B2/ja not_active Expired - Fee Related
- 2003-09-11 DE DE60334924T patent/DE60334924D1/de not_active Expired - Lifetime
- 2003-09-11 EP EP03816299A patent/EP1553927B9/de not_active Expired - Lifetime
- 2003-09-11 SI SI200331901T patent/SI1553927T1/sl unknown
- 2003-09-11 ES ES03816299T patent/ES2355723T3/es not_active Expired - Lifetime
- 2003-09-11 CA CA2498207A patent/CA2498207C/en not_active Expired - Fee Related
- 2003-09-11 WO PCT/US2003/028380 patent/WO2005000265A2/en not_active Ceased
- 2003-09-11 PT PT03816299T patent/PT1553927E/pt unknown
- 2003-09-11 AU AU2003304237A patent/AU2003304237A1/en not_active Abandoned
- 2003-09-11 US US10/659,706 patent/US7713551B2/en not_active Expired - Lifetime
- 2003-09-11 DK DK03816299.6T patent/DK1553927T3/da active
- 2003-09-11 AT AT03816299T patent/ATE487470T1/de active
-
2010
- 2010-11-26 CY CY20101101084T patent/CY1110949T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2355723T3 (es) | 2011-03-30 |
| EP1553927B1 (de) | 2010-11-10 |
| JP4878839B2 (ja) | 2012-02-15 |
| AU2003304237A8 (en) | 2005-01-13 |
| WO2005000265A2 (en) | 2005-01-06 |
| US20050031691A1 (en) | 2005-02-10 |
| CA2498207A1 (en) | 2005-01-06 |
| ATE487470T1 (de) | 2010-11-15 |
| JP2006514688A (ja) | 2006-05-11 |
| EP1553927B9 (de) | 2011-09-21 |
| US7713551B2 (en) | 2010-05-11 |
| EP1553927A2 (de) | 2005-07-20 |
| PT1553927E (pt) | 2010-11-22 |
| DK1553927T3 (da) | 2011-01-31 |
| CY1110949T1 (el) | 2015-06-10 |
| SI1553927T1 (sl) | 2010-12-31 |
| CA2498207C (en) | 2012-03-13 |
| AU2003304237A1 (en) | 2005-01-13 |
| WO2005000265A3 (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60334924D1 (de) | Anoteilchengrösse | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| ATE381317T1 (de) | Nanopartikuläre zusammensetzungen in form festen darreichungen | |
| DE60237449D1 (de) | Ammensetzungen und damit in beziehung stehende verwendungen | |
| CO5170479A1 (es) | Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado saturado y un mono de ester de acido acrilico. . | |
| DE69812343D1 (de) | Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff | |
| BR0207930A (pt) | Composições farmacêuticas lìquidas com sabor mascarado | |
| BRPI9811803B8 (pt) | comprimido multiparticular aperfeiçoado de dissolução rápida | |
| DE69835692D1 (de) | Geladene lipide und deren verwendung | |
| TNSN04023A1 (fr) | Formulation de suspension orale stabilisee | |
| TR200200562T2 (tr) | Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler | |
| CY1105908T1 (el) | Στοματικως αποσαθρουμενα δισκια που πepιλαμβανουν βενζιμιδαζολιο | |
| ATE245450T1 (de) | Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe | |
| AR038947A1 (es) | Suspension oral de sabor agradable y metodo | |
| AR043272A1 (es) | Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden | |
| ES2074269T3 (es) | Preparado de suspension acuoso para inyeccion y metodo para producir el mismo. | |
| IL154731A0 (en) | Ion-strength independent sustained release pharmaceutical formulation | |
| CO5650219A2 (es) | Pelicula antiplaca consumible refrescante del aliento | |
| EA200300110A1 (ru) | Композиция элетриптана в виде частиц | |
| NO20020829D0 (no) | Ny anvendelse av docetaxel for behandling av hepatoma | |
| ME00568A (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
| SE0001916D0 (sv) | Novel formulation | |
| JP2005535670A5 (de) | ||
| CO5640085A2 (es) | Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato | |
| NO20004816L (no) | Ny farmasøytisk formulering |